Breaking News

Shooting Reported at High School Near Seattle
Tweet TWEET

OraSure Technologies to Present at the Raymond James 35th Annual Institutional Investors Conference

OraSure Technologies to Present at the Raymond James 35th Annual Institutional
Investors Conference

BETHLEHEM, Pa., Feb. 24, 2014 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc.
(Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will
speak to the investment community at the Raymond James 35^th Annual
Institutional Investors Conference in Orlando, Florida. The conference will be
simultaneously webcast over the Internet.

Mr. Michels is scheduled to speak March 3, 2014, at approximately 8:40 am
Eastern Time (5:40 am Pacific Time). Interested investors can access the live
webcast of the presentation by going to OraSure Technologies' web site,
www.orasure.com, and clicking on the Investor Info link.A replay of the
webcast will be available on OraSure Technologies' web site for seven
days.Alternatively, you can access the live webcast of the presentation via
the following link http://www.com/webcast/rj89/osur.

About OraSure Technologies

OraSure Technologies is a leader in the development, manufacture and
distribution of oral fluid diagnostic and collection devices and other
technologies designed to detect or diagnose critical medical conditions. Its
innovative products include rapid tests for the detection of antibodies to HIV
and HCV at the point of care and testing solutions for detecting various drugs
of abuse. The Company sells the OraQuick® In-Home HIV Test, the first and only
rapid HIV test approved by the U.S. Food and Drug Administration for sale to
the consumer over-the-counter market in the U.S. In addition, the Company is a
leading provider of oral fluid sample collection, stabilization and
preparation products for molecular diagnostic applications. OraSure's
portfolio of products is sold globally to various clinical laboratories,
hospitals, clinics, community-based organizations and other public health
organizations, research and academic institutions, distributors, government
agencies, physicians' offices, and commercial and industrial entities. The
Company's products enable healthcare providers to deliver critical information
to patients, empowering them to make decisions to improve and protect their
health.

For more information on the Company, please go to www.orasure.com.

CONTACT: Ronald H. Spair
         Chief Financial Officer
         610-882-1820
         Investorinfo@orasure.com
         www.orasure.com

company logo
 
Press spacebar to pause and continue. Press esc to stop.